# Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

> **NCT01389505** · PHASE2 · UNKNOWN · sponsor: **Instituto do Coracao** · enrollment: 30 (estimated)

## Conditions studied

- Proliferative Diabetic Retinopathy

## Interventions

- **PROCEDURE:** Panretinal photocoagulation
- **PROCEDURE:** Procedure: Panretinal Photocoagulation (PRP) Drug: Intravitreous injection of Bevacizumab

## Key facts

- **NCT ID:** NCT01389505
- **Lead sponsor:** Instituto do Coracao
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-02
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01389505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01389505, "Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01389505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*